Structure, expression pattern and biological activity of molecular complex TREM-2/DAP12

Human Immunology

Volumn 74, Issue 6, 2013, Pages 730-737

  Paradowska Gorycka, Agnieszka ^a   Jurkowska, Monika ^a  

^a INSTITUTE OF RHEUMATOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

KILLER CELL ACTIVATING RECEPTOR ASSOCIATED PROTEIN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; MYELOID DIFFERENTIATION FACTOR 88; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE SYK; PROTEIN KINASE ZAP 70; PROTEIN TYROSINE KINASE; RECEPTOR; TREM 2 RECEPTOR; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ARTICLE; BIOLOGICAL ACTIVITY; BIOLOGICAL FUNCTIONS; DENDRITIC CELL; HOMEOSTASIS; HUMAN; HUMAN CHROMOSOME; IMMUNORECEPTOR TYROSINE BASED INHIBITION MOTIF; INNATE IMMUNITY; INTRACELLULAR SIGNALING; MACROPHAGE; MICROGLIA; MULTIGENE FAMILY; NEUTROPHIL; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PHAGOCYTOSIS; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN STRUCTURE; STRUCTURAL HOMOLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; GENE EXPRESSION REGULATION; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; PROTEIN BINDING; RECEPTORS, IMMUNOLOGIC; RECEPTORS, NATURAL KILLER CELL; SIGNAL TRANSDUCTION;

EID: 84877036833     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2013.02.003     Document Type: Article

References (76)

1. Love P.E., Hayes S.M. ITAM-mediated signaling by the T-cell antigen receptor. Cold Spring Harb Perspect Biol 2010, 2:a002485.
2. Blank U., Launay P., Benhamou M., Monteiro R.C. Inhibitory ITAMs as novel regulators of immunity. Immunol Rev 2009, 232:59-71.
3. Takaki R., Watson S.R., Lanier L.L. DAP12: an adapter protein with dual functionality. Immunol Rev 2006, 214:118-129.
4. Tomasello E., Vivier E. KARAP/DAP12/TYROBP: three names and a multiplicity of biological functions. Eur J Immunol 2005, 35:1670-1677.
5. Underhill D.M., Goodridge H.S. The many faces of ITAMs. Trends Immunol 2007, 28:66-73.
6. Hamerman J.A., Jarjoura J.R., Humphrey M.B., Nakamura M.C., Seaman W.E., Lanier L.L. Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12. J Immunol 2006, 177:2051-2055.
7. 25+ treg in the absence of a functional DAP12 adapter protein. Eur J Immunol 2008, 38:3191-3199.
8. Peng Q., Malhotra S., Torchia J.A., Kerr W.G., Coggeshall K.M., Humphrey M.B. TREM-2 and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1. Sci Signal 2010, 3:ra38.
9. Colonna M. DAP12 signaling: from immune cells to bone modeling and brain myelination. J Clin Invest 2003, 111:313-314.
10. Colonna M., Turnbull I., Klesney-Tait J. The enigmatic function of TREM-2 in osteoclastogenesis. Adv Exp Med Biol 2007, 602:97-105.
11. Wilson M.J., Lindquist J.A., Trowsdale J. DAP12 and KAP10 (DAP10)-novel transmembrane adapter proteins of the CD3ζ family. Immunol Res 2000, 22:21-42.
12. Turnbull I.R., Colonna M. Activating and inhibitory function of DAP12. Nat Rev Immunol 2007, 7:155-161.
13. Chang C., et al. Cutting egde: KAP10, a novel transmembrane adapter protein genetically linked to DAP12 but with unique signaling properties. J Immunol 1999, 163:4651-4654.
14. Hamerman J.A., Ni M., Killebrew J.R., Chu C.L., Lowell C.A. The expanding roles of ITAM adapters FcRγ and DAP12 in myeloid cells. Immunol Rev 2009, 232:42-58.
15. Waterman P.M., Cambier J.C. The conundrum of inhibitory signaling by ITAM-containg immunoreceptors: potential molecular mechanisms. FEBS Lett 2010, 584:4878-4882.
16. Lanier L.L., Corliss B.C., Wu J., Leong C., Philips J.H. Immunoreceptor DAP12 bearing a tyrosine-based activation motifs is involved in activating NK cells. Nature 1998, 391:703-707.
17. Call M.E., Wucherpfennig K.W., Chou J.J. The structural basis for intramembrane assembly of an activating immunoreceptor complex. Nat Immunol 2010, 11:1023-1029.
18. Lanier L.L. DAP10- and DAP12-associated receptors in innate immunity. Immunol Rev 2009, 227:150-160.
19. Aoki N., Kimura S., Xing Z. Role of DAP12 in innate and adaptive immune responses. Curr Pharm Design 2003, 9:7-10.
20. Bouchon A., Hernandez-Munain C., Cella M., Colonna M. A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells. J Exp Med 2001, 194:1111-1122.
21. van Bergen J., Koning F. The tortoise and the hare: slowly evolving T-cell responses take hastily evolving KIR. Immunology 2010, 131:301-309.
22. Yamanaka M., Kato Y., Angata T., Narimatsu H. Deletion polymorphism of SIGLEC14 and its functional implications. Glycobiology 2009, 19:841-846.
23. Aguilar H., Alvarez-Errico D., Garcia-Montero A.C., Orfao A., Sayos J., Lopez-Botet M. Molecular characterization of a novel immune receptor restricted to the monocytic lineage. J Immunol 2004, 173:6703-6711.
24. Martinez-Barriocanal A., Sayos J. Molecular and functional characterization of Cd300b, a new activating immunoglobulin receptor able to transducer signals through two different pathways. J Immunol 2006, 177:2819-2830.
25. Cao H., Lanker U., de Bono B., Traherne J.A., Trwosdale J., Barrow A.D. SIGLEC16 encodes a DAP12-associated receptor expressed in macrophages that evolved from its inhibitory counterpart SIGLEC11 and has functional and non-functional alleles in humans. Eur J Immunol 2008, 38:2303-2315.
26. Allcock R.J.N., Barrow A.D., Forbes S., Beck S., Trowsdale J. The human TREM gene cluster at 6p21.1 encodes both activating and inhibitory single IgV domain receptors and includes NKp44. Eur J Immunol 2003, 33:567-577.
27. Klesney-Tait J., Turnbull I.R., Colonna M. The TREM receptor family and signal integration. Nat Immunol 2007, 7:1266-1273.
28. Whittaker G.C., et al. The linker for activation of B cells (LAB)/non-T cell activation linker (NTAL) regulates triggering receptor expressed on myeloid cells (TREM)-2 signaling and macrophage inflammatory responses independently of the linker for activation of T cells. J Biol Chem 2010, 285:2976-2985.
29. Quan D.N., Cooper M.D., Potter J.L., Roberts M.H., Cheng H., Jarvis G.A. TREM-2 binds to lipopolisaccharides of Neisseria gonorrhoeae and is expressed on reproductive tract epithelial cells. Mucosal Immunol 2008, 1:229-238.
30. Molloy E.J. Triggering receptor expressed on myeloid cells (TREM) family and the application of its antagonist. Recent Pat Antiinfect Drug Discov 2009, 4:51-56.
31. Bouchon A., Dietrich J., Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 2000, 164:4991-4995.
32. Ford J.W., McVicar D.W. TREM and TREM-like receptors in inflammation and disease. Curr Opin Immunol 2009, 21:38-46.
33. Colonna M. TREMS in the immune system and beyond. Nat Rev Immunol 2003, 3:1-9.
34. Schleinitz N., et al. Pattern of DAP12 expression in leukocytes from both healthy and systemic lupus erythematosus patients. PLoS ONE 2009, 4:e6264.
35. Daws M.R., Lanier L.L., Seaman W.E., Ryan J.C. Cloning and characterization of a novel mouse myeloid DAP12-associated receptor family. Eur J Immunol 2001, 31:783-791.
36. Ito H., Hamerman J.A. TREM-2, triggering receptor expressed on myeloid cell-2, negatively regulates TLR. Eur J Immunol 2012, 42:176-185.
37. Hamerman J.A., Jarjoura J.R., Humphrey M.B., Nakamura M.C., Seaman W.E., Lanier L.L. Cutting edge: inhibition of TLR and FcR resposnes in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12. J Immunol 2006, 177:2051-2055.
38. Turnbull I.R., et al. Cutting edge: TREM-2 attenuates macrophage activation. J Immunol 2006, 177:3520-3524.
39. Paloneva J., et al. DAP12/TREM-2 deficiency results in impired osteoclast differentiation and osteoporotic features. J Exp Med 2003, 198:669-675.
40. Cella M., Buonsanti C., Strader C., Kondo T., Salmaggi A., Colonna M. Impaired differentiation of osteoclast in TREM-2-deficient individuals. J Exp Med 2003, 198:645-651.
41. Sessa G., et al. Distribution and signaling of TREM-2/DAP12, the receptor system mutated in human polycystic lipomembraneous osteodysplasia with sclerosing leukoencephalopathy dementia. Eur J Neurosci 2004, 20:2617-2628.
42. Piccio L., et al. Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis. Eur J Immunol 2007, 37:1290-1301.
43. Guha M., Mackman N. The phosphatidylinositol 3-kinase-akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J Biol Chem 2002, 277:32124-32132.
44. Qiao M., Sheng S., Pardee A.B. Metastasis and AKT activation. Cell Cycle 2008, 7:2991-2996.
45. Daws M.R., Sullam P.M., Niemi E.C., Chen T.T., Tchao N.K., Seaman W.E. Pattern recognition by TREM-2: binding of anionic ligands. J Immunol 2003, 171:594-599.
46. Smith-Garvin J.E., Koretzky G.A., Jordan M.S. T cell activation. Annu Rev Immunol 2009, 27:591-619.
47. Fuller D.M., Zhu M., Ou-Yang C.W., Sullivan S.A., Zhang W. A tale of two TRAPs: LAT and LAB in the regulation of lymphocyte development, activation and autoimmunity. Immunol Res 2011, 49:97-108.
48. Sommers C.L., Samelson L.E., Love P.E. LAT: a T lymphocyte adapter protein that couples the antigen receptor to downstream signaling pathways. BioEssays 2004, 26:61-67.
49. Orr S.J., McVicar D.W. LAB/NTAL/Lat2: a force to be reckoned with in all leukocytes?. J Leukoc Biol 2011, 89:11-19.
50. Schwartzberg P.L., Finkelstein L.D., Readinger J.A. Tec-family kinases: regulators of T-helper-cell differentiation. Nat Rev Immunol 2005, 5:284-295.
51. Abraham R.T., Weiss A. Jurkat T cells and development of the T-cell receptor signaling paradigm. Nat Rev Immunol 2004, 4:301-308.
52. Okkenhaug K., Ali K., Vanhaesebroeck B. Antigen receptor signaling: a distinctive role for the p110δ isoform of PI3K. Trends Immunol 2007, 28:80-87.
53. Volna P., et al. Negative regulation of mast cell signaling and function by the adaptor LAB/NTAL. J Exp Med 2004, 200:1001-1013.
54. Lucas J.A., Miller A.T., Atherly L.O., Berg L.J. The role of Tec family kinases in T cell development and function. Immunol Rev 2003, 191:119-138.
55. Ivashkiv L.B. Cross-regulation of signaling by ITAM-associated receptors. Nat Immunol 2009, 10:340-347.
56. Hamerman J.A., Tchao N.K., Lowell C.A., Lanier L.L. Enhanced toll-like receptor responses in the absence of signaling adapter DAP12. Nat Immunol 2005, 6:579-586.
57. Kagan J.C., Medzhitov R. Phosphoinositide-mediated adaptor recruitment controls toll-like receptor signaling. Cell 2006, 125:943-955.
58. Kawai T., Akira S. TLR signaling. Semin Immunol 2007, 19:24-32.
59. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on toll-like receptors. Nat Immunol 2010, 11:373-384.
60. Kawai T., Akira S. TLR signaling. Cell Death Differ 2006, 13:816-825.
61. Santos-Sierra S., Deshmukh S.D., Kalnitski J., Küenzi P., Wymann M.P., Golenbock D.T., et al. Mal connects TLR2 to PI3Kinase activation and phagocyte polarization. EMBO J 2009, 28:2018-2027.
62. Strassheim D., et al. Phosphoinositide 3-kinase and Akt occupy central roles in inflammatory responses of toll-like receptor 2-stimulated neutrophils. J Immunol 2004, 172:5727-5733.
63. Piccio L., et al. Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation. Brain 2008, 131:3081-3091.
64. Hara H., Saito T. CARD9 versus CARMA1 in innate and adaptive immunity. Trends Immunol 2009, 30:234-242.
65. Akira S. Toll-like receptor signaling. J Biol Chem 2003, 278:38105-38108.
66. N'Diaye E.N., Branda C.S., Branda S.S., Nevarez L., et al. TREM-2 (triggering receptor expressed on myeloid cells 2) is a phagocytic receptor for bacteria. J Cell Biol 2009, 184:215-223.
67. Tomasello E., et al. Combined natural killer cell and dendritic cell functional deficiency in KARAP/DAP12 loss-of-function mutant mice. Immunity 2000, 13:355-364.
68. Helming L., et al. Essential role of DAP12 signaling in macrophage programming into a fusion-competent state. Sci Signal 2008, 1:ra11.
69. Radhakrishnan S., et al. TREM-2 mediated signaling induces antigen uptake and retention in mature myeloid dendritic cells. J Immunol 2008, 181:7863-7872.
70. Kalliolias G.D., Zhao B., Triantafyllopoulou A., Park-Min K.H., Ivashkiv L.B. IL-27 inhibits human osteoclastogenesis by abrogating RANKL-mediated induction of NFATc1 and suppressing proximal RANK signaling. Arthritis Rheum 2010, 62:402.
71. Kaifu T., et al. Osteopetrosis and thalamic hypomyelinosis with synaptic degradation in DAP12-deficient mice. J Clin Invest 2003, 111:323-332.
72. Humphrey M.B., et al. The signaling adapter protein DAP12 regulates multinucleation during osteoclast development. J Bone Miner Res 2004, 19:224-234.
73. Humphery M.B., et al. TREM2, a DAP12-associated receptor, regulates osteoclast differentiation and function. J Bone Miner Res 2006, 21:237-345.
74. Anginot A., Dacquin R., Mazzorana M., Jurdic P. Lymphocytes and the DAP12 adaptor are key regulators of osteoclast activation associated with gonadal failure. PLoS One 2007, 7:e585.
75. Takahashi K., Rochford C.D., Neumann H. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J Exp Med 2005, 201:647-657.
76. Charles J.F., et al. The innate immune response to Salmonella by macrophages is dependent on TREM2-DAP12. Infect Immun 2008, 76:2439-2447.